IRIS Accounts Production v24.3.0.553 11765643 Board of Directors 1.2.23 31.1.24 31.1.24 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh117656432023-01-31117656432024-01-31117656432023-02-012024-01-31117656432022-01-31117656432022-02-012023-01-31117656432023-01-3111765643ns15:EnglandWales2023-02-012024-01-3111765643ns14:PoundSterling2023-02-012024-01-3111765643ns10:Director12023-02-012024-01-3111765643ns10:PrivateLimitedCompanyLtd2023-02-012024-01-3111765643ns10:SmallEntities2023-02-012024-01-3111765643ns10:AuditExempt-NoAccountantsReport2023-02-012024-01-3111765643ns10:SmallCompaniesRegimeForDirectorsReport2023-02-012024-01-3111765643ns10:SmallCompaniesRegimeForAccounts2023-02-012024-01-3111765643ns10:AbridgedAccounts2023-02-012024-01-3111765643ns10:OrdinaryShareClass12023-02-012024-01-311176564312023-02-012024-01-3111765643ns10:Director22023-02-012024-01-3111765643ns10:RegisteredOffice2023-02-012024-01-3111765643ns5:CurrentFinancialInstruments2024-01-3111765643ns5:CurrentFinancialInstruments2023-01-3111765643ns5:Non-currentFinancialInstruments2024-01-3111765643ns5:Non-currentFinancialInstruments2023-01-3111765643ns5:ShareCapital2024-01-3111765643ns5:ShareCapital2023-01-3111765643ns5:RetainedEarningsAccumulatedLosses2024-01-3111765643ns5:RetainedEarningsAccumulatedLosses2023-01-3111765643ns10:OrdinaryShareClass12024-01-31
REGISTERED NUMBER: 11765643 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 January 2024

for

Varang Healthcare Limited

Previously known as
Varang Recruitment Solutions Limited

Varang Healthcare Limited (Registered number: 11765643)

Contents of the Financial Statements
for the Year Ended 31 January 2024










Page

Company Information 1

Abridged Statement of Financial Position 2

Notes to the Financial Statements 4


Varang Healthcare Limited

Company Information
for the Year Ended 31 January 2024







DIRECTORS: P K Neupane
P R Neupane





REGISTERED OFFICE: 268 Bath Road
Slough
SL1 4DX





REGISTERED NUMBER: 11765643 (England and Wales)





ACCOUNTANTS: ADHK ACCOUNTANTS
Chartered Certified Accountants
Boundary House
Cricket Field Road
Uxbridge
UB8 1QG

Varang Healthcare Limited (Registered number: 11765643)

Abridged Statement of Financial Position
31 January 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 431 2,498

CURRENT ASSETS
Debtors 209,663 227,268
Cash at bank and in hand 436,064 326,884
645,727 554,152
CREDITORS
Amounts falling due within one year 117,161 151,056
NET CURRENT ASSETS 528,566 403,096
TOTAL ASSETS LESS CURRENT
LIABILITIES

528,997

405,594

CREDITORS
Amounts falling due after more than one year 13,382 23,040
NET ASSETS 515,615 382,554

CAPITAL AND RESERVES
Called up share capital 6 100 100
Retained earnings 515,515 382,454
SHAREHOLDERS' FUNDS 515,615 382,554

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Varang Healthcare Limited (Registered number: 11765643)

Abridged Statement of Financial Position - continued
31 January 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Income Statement and an abridged Statement of Financial Position for the year ended 31 January 2024 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 24 October 2024 and were signed on its behalf by:





P R Neupane - Director


Varang Healthcare Limited (Registered number: 11765643)

Notes to the Financial Statements
for the Year Ended 31 January 2024


1. STATUTORY INFORMATION

Varang Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents the net value of services rendered excluding value added tax.

Tangible fixed assets
Tangible fixed assets are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using either a straight line or reducing balance method, as indicated below.

Depreciation is provided on the following basis:

Computer and equipment - 50% Straight Line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Varang Healthcare Limited (Registered number: 11765643)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2024


2. ACCOUNTING POLICIES - continued

Debtors
Basic financial assets, including trade and other debtors, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Such assets are subsequently carried at amortised cost using the effective interest method, less any impairment.

Cash and cash equivalent
Cash and cash equivalents are represented by cash in hand, deposits held at call with financial institutions, and other short-term highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

Creditors
Basic financial liabilities, including trade and other creditors, loans from third parties and loans from related parties, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Such instruments are subsequently carried at amortised cost using the effective interest method, less any impairment.

Financial instruments
The Company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in non-puttable ordinary shares.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in profit or loss.

Financial assets and liabilities are offset and the net amount reported in the Balance Sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 50 (2023 - 62 ) .

4. TANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 February 2023 9,744
Additions 862
At 31 January 2024 10,606
DEPRECIATION
At 1 February 2023 7,246
Charge for year 2,929
At 31 January 2024 10,175
NET BOOK VALUE
At 31 January 2024 431
At 31 January 2023 2,498

Varang Healthcare Limited (Registered number: 11765643)

Notes to the Financial Statements - continued
for the Year Ended 31 January 2024


5. LEASING AGREEMENTS
At the year end, the company's operating lease commitment was £22,693 (2023: £31,428).

6. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
100 Ordinary £1 100 100

7. RELATED PARTY DISCLOSURES

During the year, total dividends of £80,000 (2023 - £36,300) were paid to the directors .

Amount owed by group undertakings represent the amount due from Varang Properties Limited, where Mr P R Neupane, a director of the company, is the sole director and and 100% shareholder.

8. ULTIMATE CONTROLLING PARTY

The company is under the control of the directors.